Uncategorized Archives - Page 945 of 985

MondayDec 12, 2016 4:25 pm

Medical Transcription Billing, Corp. (MTBC) (MTBCP) is Revolutionizing Revenue Cycle Management

Revenue cycle management (RCM) is not what it used to be. There was a time when a visit to a small medical practice meant paying the doctor or his receptionist in cash. RCM for the physician was, essentially, receiving cash from a patient and depositing that cash. Alas! Those halcyon days are gone. As the scope and cost of healthcare services in the most advanced nation on earth have grown, so too have the complexities of the supporting reimbursement systems, giving rise to entirely new industries in healthcare information technology (HIT) and revenue cycle management (RCM). But these complexities also…

MondayDec 12, 2016 3:25 pm

Net Element, Inc. (NETE) Receives Update from SeeThruEquity

Before the opening bell, leading independent equity research and corporate access firm SeeThruEquity announced the release of a company update covering Net Element, Inc. (NASDAQ: NETE). The update follows Net Element’s November release of its third quarter financial results, which included a 10 percent year-over-year increase in total revenues driven by strong performance from the company’s North America Transactions segment. With revenues up an impressive 55 percent year-over-year for the first nine months of 2016, SeeThruEquity classified Net Element as “an intriguing high risk / high reward growth company in the financial technology space.” In addition to its strong revenue…

MondayDec 12, 2016 1:14 pm

Nano Dimension Ltd. (NNDM) Addressing the Tech Industry’s Biggest Bottleneck with Innovative 3D Printing Solutions

Nano Dimension Ltd. (NASDAQ: NNDM) is an Israel-based technology company focused on the development of advanced 3D printed electronics systems and advanced additive manufacturing. Since its founding in 2012, the company has successfully established a position at the forefront of the rapidly expanding 3D printing market by relying on a combination of three advanced technologies, including the 3D inkjet, proprietary 3D software and innovative nanomaterials. Among its most well-known offerings, Nano Dimension developed the first 3D printer on the market dedicated to the creation of multi-layer printed circuit boards (PCBs), as well as a series of advanced nanotechnology-based conductive and…

MondayDec 12, 2016 12:26 pm

Social Reality, Inc. (NASDAQ: SRAX) is “One to Watch”

Social Reality, Inc. (NASDAQ: SRAX) is an Internet advertising company focused on providing tools that automate the digital advertising market. The company has developed three core platforms to deliver a complete set of marketing tools and services that create new and measurable opportunities for brands, agencies and publishers to target, reach and monetize their audiences. SRAX is the company’s real-time bidding management platform for launching, distributing, tracking and optimizing social, digital media and consumer engagement campaigns. The underlying technology powers a programmatic marketplace that makes it easier and more efficient to optimize display, video, mobile and in-app advertising on multiple…

MondayDec 12, 2016 8:30 am

Trump’s Special F X

Let’s face it, optimism is one of the most powerful market drivers and, thanks to the President Elect’s actions, Ford (NYSE: F), U.S. Steel (NYSE: X), and United Technologies Corp. (NYSE: UTX), Carrier’s parent corporation, are making moves that have Americans believing that manufacturing jobs are returning to America, in one of the best feel good stories in a generation. The optimism is further fueled in knowing that this trend is just beginning. For most companies, the proposed tax cuts should directly translate into bigger bottom lines and bigger budgets for important needs, so many companies, like Social Reality (NASDAQ:…

FridayDec 09, 2016 1:07 pm

MediWound Ltd. (MDWD) Receives Consensus Analysts Rating of ‘Buy’

MediWound Ltd. (NASDAQ: MDWD) is a biopharmaceutical company in the business of developing, manufacturing, and globally commercializing products that treat severe burns and wounds. In 2012, MediWound’s innovative drug, NexoBrid™, a burn and wound eschar removal agent, was approved by the European Medicines Agency (EMA) via a centralized procedure. The drug was given orphan indication for removal of dead and damaged skin in adults with burns that are deep partial and full thickness thermal burns. NexoBrid™ was launched throughout Europe and is now being used in patients with hospitalized burns and wounds. MediWound has initiated phase III clinical trials on…

FridayDec 09, 2016 9:13 am

Globus Medical, Inc. (GMED) Class A Stock Sees Significant Volume Spike Moving Into 2017

As an eventful year for Globus Medical, Inc. (NYSE: GMED) is nearing an end, the leading medical device company experienced a substantial surge in trading volume on December 06. Equities.com (http://nnw.fm/Dxdw3) noted a 1.3% gain of Globus Medical, Inc. Class A stock, closing at $23.31. The stock, which averages a daily volume of 1.11 million shares over the last month, captured the attention of numerous institutional investors and analysts when a surge of 11.57 million shares traded hands on 28,116 trades. The article states, “Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen…

ThursdayDec 08, 2016 4:32 pm

Intellipharmaceutics International, Inc. (IPCI) Receives Aegis Update

Intellipharmaceutics International, Inc. (NASDAQ: IPCI) is a pharmaceutical company in the business of researching, developing, and manufacturing new and generic controlled and targeted release oral solid dosage drugs. The company has a large product portfolio which all follow a New Drug Application (NDA) 505(b)(2) U.S. Food and Drug Administration (FDA) regulatory pathway. The company’s controlled-release generic products follow an Abbreviated New Drug Application (ANDA) pathway. IPCI currently has 11 products in the pipeline, more than half of which have either been filed for FDA approval or have already been approved. Two products, Regabatin™ XR and Carvedilol, are still in clinical…

ThursdayDec 08, 2016 3:31 pm

Revance Therapeutics, Inc. (RVNC) is “One to Watch”

Revance Therapeutics, Inc. (NASDAQ: RVNC), a biotechnology company focused on the development, commercialization, and manufacture of botulinum toxin products for use in aesthetic and therapeutic indications, including dermatology and neurology, recently announced its operating results for the third quarter of 2016 ended September 30. A summary of the company’s financial results highlighted research and development expenses of $10.3 million for the three-month period, $2.7 million less than in the same quarter of 2015. The decrease in expenses was largely attributable to a reduction in clinical trial activities. Research and development costs for the nine-month period were up $5.3 million. The…

ThursdayDec 08, 2016 2:35 pm

Singlepoint, Inc. (SING) on Standby as California Looks to Trump to Address Marijuana Industry Banking Woes

Now that residents of the Golden State have approved Proposition 64, California joins the District of Columbia and the states of Alaska, Colorado, Maine, Massachusetts, Nevada, Oregon, and Washington in legalizing the recreational use of marijuana for adults. Together, these eight states and the U.S. capital generate about one-quarter of U.S. gross domestic product (GDP). If they were one nation-state, that entity would rank as the world’s third largest economy. Based in one of those states, Nevada, Singlepoint, Inc. (OTC: SING) is poised to profit from these promising presentiments. It recently revived its SingleSeed subsidiary, which several years ago began…